HCPCS Level IIdrugActive
J1652
Fondaparinux sodium
BETOS: O1E
Effective: 2003-01-01
Referenced in 1 policies
Description
Injection, fondaparinux sodium, 0.5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Fondaparinux Sodium
Manufacturer
Sandoz Inc.
HCPCS Dosage
0.5 MG
Billing Units
5.0000
27
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.